Total Funding
92
74
Total FundingConvertible Note raised
Growth Score
0 pts
Heat Score
17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1628
Powering precision proteomics to enable to the earliest detection of disease.
- Mike Nerenberg: Chief Medical OfficerPast Role: Superfluid Dx, Chief Medical Officer
Xiao-Jun Ma: Chief Technology OfficerPast Role: Advanced Cell Diagnostics, Chief Scientific Officer
About the Company
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time. The company was founded in 2018 and is headquartered in Fremont, California.
